Quantcast
Last updated on April 19, 2014 at 8:32 EDT

Latest hemoglobin Stories

2012-05-18 22:58:20

Evidence that comparing genes across species is biologically useful Researchers at the SIB Swiss Institute of Bioinformatics and the EMBL-European Bioinformatics Institute have confirmed the long-held conjecture that studying the genes we share with other animals is a viable means of extrapolating information about human biology. The study, published in the open access journal PLoS Computational Biology, shows how bioinformatics makes it possible to test the conjecture. Scientists have...

2012-05-03 06:26:42

IRVINE, Calif., May 3, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced it has signed a three-year, dual-source agreement with Novation, the healthcare contracting services company of VHA Inc. and the University Health System Consortium (UHC). The agreement, effective May 1, 2012, covers Masimo SET® pulse oximetry and Masimo rainbow® SET Pulse CO-Oximetry(TM) and rainbow® Acoustic Monitoring, including standalone monitoring devices, handhelds, and sensors. The...

2012-04-25 20:22:46

A new monitoring method and blood test may provide early warnings when a child's brain isn't getting enough blood during heart surgery, according to new research presented during the American Heart Association's Emerging Science Series webinar. Brain injury occurs in 30 percent to 70 percent of infants and children undergoing repair of congenital heart defects. A congenital heart defect is a heart abnormality present at birth. Out of 1,000 live births in the United States, about 8 babies...

2012-03-28 17:19:12

Researchers say their method, tested in human cells, may offer the first viable approach to gene transfer in sickle cell anemia A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also developed a test to predict patient response before treatment. This study's findings, published in PLoS ONE, represents a new approach to...

2012-03-12 07:10:00

SAN DIEGO, March 12, 2012 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing. The Series B Extension is being funded by its existing investors: Aberdare Ventures, De Novo Ventures, Forward Ventures, Latterell Venture Partners and Lilly Ventures. Proceeds from the financing will be...

2012-01-20 10:45:38

Drugs that treat anemia are critical for many who have kidney disease Highlights     More than 20 million adults in the United States have chronic kidney disease.     Drugs that treat red blood cell deficiencies are critical for maintaining many chronic kidney disease patients' health.     Experts comment on newly released federal recommendations for these drugs. The U.S. Food and Drug Administration (FDA) recently recommended that...

2012-01-17 15:25:00

LAS VEGAS, Jan. 17, 2012 /PRNewswire/ -- Doctors at Children's Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts Sunday, January 15 during the "Play Without Pain: Children's Sickle Cell Benefit," a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children's Hospital Boston. Held at Caesars...

2012-01-12 12:52:00

SAN DIEGO, Jan. 12, 2012 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease. MP4CO is designed to deliver therapeutic levels of carbon monoxide (CO)...

2012-01-09 11:23:00

IRVINE, Calif., Jan. 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance and full market commercial launch of the Masimo Pronto-7®--a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo: http://photos.prnewswire.com/prnh/20120109/LA31863) Hailed as a "potential game-changing technology," Dr. Andrew J. Schuman--adjunct assistant professor of...